News & Events

Join StageBio at the American College of Toxicology’s 43rd Annual Meeting

The StageBio team is looking forward to sponsoring the American College of Toxicology’s annual meeting this year in Denver, Colorado on November 13-16 2022.

ACT’s annual meeting includes three days of educational and networking opportunities including scientific sessions, exhibits and networking events, Poster Sessions, and an Awards Ceremony, all tailored to toxicologists, industry consultants, and other professionals.

Join us for our Talking Tox Session, “Ocular Toxicity Studies: Technical Considerations and Pathology Reporting Expectations”, on November 13 from 12:00-12:55MST in Summit 7. This session will be led by Dr. Stephanie Shrader, Director, General Toxicologic Pathology, of StageBio. Attendees can expect to gain a better understanding on technical study considerations including species selection, anatomic differences, necropsy and histology techniques, and refining pathology reporting by reviewing basic report components, interpretation of findings, adversity determination, and ophthalmic examination correlates. For more information on this session, please go here.

During exhibit time, stop by StageBio’s booth #300 and connect with our team. The ACT Expo Live! will be open November 14-16 for attendees to connect and make valuable professional connections.

ACT is committed to the health and safety of all attendees. ACT is encouraging the use of face masks and will follow local and CDC protocols relevant to the COVID-19 pandemic. For more information, go here.

See you at ACT November 13-16!

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. We will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 30+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity, and client satisfaction. Learn more at

Back to Index

Learn more about StageBio’s COVID-19 response